SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-224171
Filing Date
2022-08-18
Accepted
2022-08-18 16:46:29
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d373822d10q.htm   iXBRL 10-Q 878558
2 EX-31.1 d373822dex311.htm EX-31.1 11130
3 EX-31.2 d373822dex312.htm EX-31.2 11130
4 EX-32.1 d373822dex321.htm EX-32.1 3959
5 EX-32.2 d373822dex322.htm EX-32.2 3822
  Complete submission text file 0001193125-22-224171.txt   5188812

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apgn-20220630.xsd EX-101.SCH 51191
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apgn-20220630_cal.xml EX-101.CAL 24603
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apgn-20220630_def.xml EX-101.DEF 273521
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apgn-20220630_lab.xml EX-101.LAB 372346
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apgn-20220630_pre.xml EX-101.PRE 335632
48 EXTRACTED XBRL INSTANCE DOCUMENT d373822d10q_htm.xml XML 767274
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39488 | Film No.: 221177960
SIC: 2834 Pharmaceutical Preparations